Losada, E.
Soldevila, B.
Ali, M.S.
Martínez-Laguna, D.
Nogués, X.
Puig-Domingo, M.
Díez-Pérez, A.
Mauricio, D.
Prieto-Alhambra, D.
Article History
Received: 12 January 2018
Accepted: 16 May 2018
First Online: 2 June 2018
Compliance with ethical standards
:
: D.P.A. declares that his department/research group has received unrestricted research grants from Amgen, Servier Laboratoires, and Bioiberica; XN has been paid by Amgen and Lilly for developing and delivering educational presentations; D.M. declares receipt of honoraria from Abbott, Astra Zeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Ferrer, GlaxoSmithKline, Eli Lilly, Medtronic, Merck Sharp & Dohme, Novartis, Novo Nordisk, and Sanofi for consulting and presentations. ADP has been a speaker or advisory board member for Lilly, Amgen, GSK, and UCB and owns stocks of Active Life Scientific; E.L.G., B.S., M.S.A., M.P.D., and D.M.L. have no conflicts of interest.